vs
AXCELIS TECHNOLOGIES INC（ACLS）与Sotera Health Co（SHC）财务数据对比。点击上方公司名可切换其他公司
Sotera Health Co的季度营收约是AXCELIS TECHNOLOGIES INC的1.3倍（$303.4M vs $238.3M），AXCELIS TECHNOLOGIES INC净利率更高（14.4% vs 11.5%，领先2.9%），Sotera Health Co同比增速更快（4.6% vs -5.6%），Sotera Health Co自由现金流更多（$52.4M vs $-8.9M），过去两年Sotera Health Co的营收复合增速更高（10.6% vs -2.8%）
Axcelis Technologies是一家美国半导体设备供应商，1995年成立，总部位于美国马萨诸塞州贝弗利。公司面向全球半导体制造行业，从事半导体生产核心设备的设计、制造及服务，主营产品包括高中电流、高能离子注入系统以及半导体芯片制造用固化系统。
Sotera Health Co是全球领先的医疗安全解决方案提供商，面向医疗器械厂商、制药企业、食品及消费品公司提供灭菌服务、实验室分析检测与合规咨询支持，帮助客户满足监管要求，保障上市产品的使用安全。
ACLS vs SHC — 直观对比
营收规模更大
SHC
是对方的1.3倍
$238.3M
营收增速更快
SHC
高出10.1%
-5.6%
净利率更高
ACLS
高出2.9%
11.5%
自由现金流更多
SHC
多$61.3M
$-8.9M
两年增速更快
SHC
近两年复合增速
-2.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $238.3M | $303.4M |
| 净利润 | $34.3M | $34.8M |
| 毛利率 | 47.0% | 54.7% |
| 营业利润率 | 15.2% | 23.2% |
| 净利率 | 14.4% | 11.5% |
| 营收同比 | -5.6% | 4.6% |
| 净利润同比 | -31.3% | 182.8% |
| 每股收益（稀释后） | $1.11 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACLSSHC
| Q4 25 | $238.3M | $303.4M | ||
| Q3 25 | $213.6M | $311.3M | ||
| Q2 25 | $194.5M | $294.3M | ||
| Q1 25 | $192.6M | $254.5M | ||
| Q4 24 | $252.4M | $290.2M | ||
| Q3 24 | $256.6M | $285.5M | ||
| Q2 24 | $256.5M | $276.6M | ||
| Q1 24 | $252.4M | $248.2M |
净利润ACLSSHC
| Q4 25 | $34.3M | $34.8M | ||
| Q3 25 | $26.0M | $48.4M | ||
| Q2 25 | $31.4M | $8.0M | ||
| Q1 25 | $28.6M | $-13.3M | ||
| Q4 24 | $50.0M | $12.3M | ||
| Q3 24 | $48.6M | $17.0M | ||
| Q2 24 | $50.9M | $8.8M | ||
| Q1 24 | $51.6M | $6.3M |
毛利率ACLSSHC
| Q4 25 | 47.0% | 54.7% | ||
| Q3 25 | 41.6% | 57.0% | ||
| Q2 25 | 44.9% | 56.6% | ||
| Q1 25 | 46.1% | 53.2% | ||
| Q4 24 | 46.0% | 56.6% | ||
| Q3 24 | 42.9% | 55.4% | ||
| Q2 24 | 43.8% | 55.2% | ||
| Q1 24 | 46.0% | 51.2% |
营业利润率ACLSSHC
| Q4 25 | 15.2% | 23.2% | ||
| Q3 25 | 11.7% | 23.4% | ||
| Q2 25 | 14.9% | 6.4% | ||
| Q1 25 | 15.1% | -5.8% | ||
| Q4 24 | 21.6% | 30.0% | ||
| Q3 24 | 18.3% | 28.2% | ||
| Q2 24 | 20.6% | 27.8% | ||
| Q1 24 | 22.4% | 21.4% |
净利率ACLSSHC
| Q4 25 | 14.4% | 11.5% | ||
| Q3 25 | 12.2% | 15.5% | ||
| Q2 25 | 16.1% | 2.7% | ||
| Q1 25 | 14.8% | -5.2% | ||
| Q4 24 | 19.8% | 4.2% | ||
| Q3 24 | 18.9% | 6.0% | ||
| Q2 24 | 19.8% | 3.2% | ||
| Q1 24 | 20.4% | 2.5% |
每股收益（稀释后）ACLSSHC
| Q4 25 | $1.11 | $0.12 | ||
| Q3 25 | $0.83 | $0.17 | ||
| Q2 25 | $0.98 | $0.03 | ||
| Q1 25 | $0.88 | $-0.05 | ||
| Q4 24 | $1.54 | $0.05 | ||
| Q3 24 | $1.49 | $0.06 | ||
| Q2 24 | $1.55 | $0.03 | ||
| Q1 24 | $1.57 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $374.3M | $344.6M |
| 总债务越低越好 | — | $2.1B |
| 股东权益账面价值 | $1.0B | $606.0M |
| 总资产 | $1.4B | $3.3B |
| 负债/权益比越低杠杆越低 | — | 3.53× |
8季度趋势，按日历期对齐
现金及短期投资ACLSSHC
| Q4 25 | $374.3M | $344.6M | ||
| Q3 25 | $449.6M | $299.2M | ||
| Q2 25 | $549.8M | $332.4M | ||
| Q1 25 | $587.1M | $304.4M | ||
| Q4 24 | $571.3M | $277.2M | ||
| Q3 24 | $579.4M | $306.7M | ||
| Q2 24 | $548.3M | $246.1M | ||
| Q1 24 | $530.2M | $261.1M |
总债务ACLSSHC
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $2.2B |
股东权益ACLSSHC
| Q4 25 | $1.0B | $606.0M | ||
| Q3 25 | $1.0B | $550.5M | ||
| Q2 25 | $1.0B | $511.3M | ||
| Q1 25 | $1.0B | $414.1M | ||
| Q4 24 | $1.0B | $404.9M | ||
| Q3 24 | $975.6M | $470.2M | ||
| Q2 24 | $934.9M | $422.8M | ||
| Q1 24 | $901.7M | $429.4M |
总资产ACLSSHC
| Q4 25 | $1.4B | $3.3B | ||
| Q3 25 | $1.4B | $3.2B | ||
| Q2 25 | $1.3B | $3.2B | ||
| Q1 25 | $1.3B | $3.1B | ||
| Q4 24 | $1.3B | $3.1B | ||
| Q3 24 | $1.3B | $3.1B | ||
| Q2 24 | $1.3B | $3.1B | ||
| Q1 24 | $1.3B | $3.1B |
负债/权益比ACLSSHC
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.89× | ||
| Q2 25 | — | 4.34× | ||
| Q1 25 | — | 5.36× | ||
| Q4 24 | — | 5.49× | ||
| Q3 24 | — | 4.73× | ||
| Q2 24 | — | 5.26× | ||
| Q1 24 | — | 5.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $103.1M |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | $52.4M |
| 自由现金流率自由现金流/营收 | -3.7% | 17.3% |
| 资本支出强度资本支出/营收 | 1.0% | 16.7% |
| 现金转化率经营现金流/净利润 | -0.19× | 2.96× |
| 过去12个月自由现金流最近4个季度 | $107.0M | $149.2M |
8季度趋势，按日历期对齐
经营现金流ACLSSHC
| Q4 25 | $-6.6M | $103.1M | ||
| Q3 25 | $45.4M | $71.2M | ||
| Q2 25 | $39.7M | $57.4M | ||
| Q1 25 | $39.8M | $55.5M | ||
| Q4 24 | $12.8M | $55.7M | ||
| Q3 24 | $45.7M | $97.5M | ||
| Q2 24 | $40.1M | $61.3M | ||
| Q1 24 | $42.2M | $9.7M |
自由现金流ACLSSHC
| Q4 25 | $-8.9M | $52.4M | ||
| Q3 25 | $43.3M | $35.0M | ||
| Q2 25 | $37.7M | $26.2M | ||
| Q1 25 | $34.8M | $35.6M | ||
| Q4 24 | $8.1M | $-10.2M | ||
| Q3 24 | $41.8M | $61.1M | ||
| Q2 24 | $38.1M | $19.4M | ||
| Q1 24 | $40.6M | $-25.2M |
自由现金流率ACLSSHC
| Q4 25 | -3.7% | 17.3% | ||
| Q3 25 | 20.3% | 11.2% | ||
| Q2 25 | 19.4% | 8.9% | ||
| Q1 25 | 18.1% | 14.0% | ||
| Q4 24 | 3.2% | -3.5% | ||
| Q3 24 | 16.3% | 21.4% | ||
| Q2 24 | 14.8% | 7.0% | ||
| Q1 24 | 16.1% | -10.2% |
资本支出强度ACLSSHC
| Q4 25 | 1.0% | 16.7% | ||
| Q3 25 | 0.9% | 11.6% | ||
| Q2 25 | 1.0% | 10.6% | ||
| Q1 25 | 2.6% | 7.8% | ||
| Q4 24 | 1.8% | 22.7% | ||
| Q3 24 | 1.5% | 12.7% | ||
| Q2 24 | 0.8% | 15.2% | ||
| Q1 24 | 0.6% | 14.1% |
现金转化率ACLSSHC
| Q4 25 | -0.19× | 2.96× | ||
| Q3 25 | 1.75× | 1.47× | ||
| Q2 25 | 1.27× | 7.21× | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.26× | 4.52× | ||
| Q3 24 | 0.94× | 5.73× | ||
| Q2 24 | 0.79× | 7.00× | ||
| Q1 24 | 0.82× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACLS
| Products | $224.6M | 94% |
| Services | $13.7M | 6% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
